Role of Priclinical and clinical study NIA/KC/2022/01 In The Management of Vyanabala Vaishmya (Essential Hypertention)

Ã¢â?¬Å?Preclinical and Clinical study to evaluate the safety and efficacy of NIA/KC/2022/01 in the management of Vyanbala Vaishamyam with Special reference to Primary Hypertension Ã¢â?¬? - No

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/045652

Enrollment

120

Registered

2022-09-19

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R030- Elevated blood-pressure reading, without diagnosis of hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to sign the consent form for the clinical trial. 2. Patients belonging to either sex between the age group 18 to 59 years. 3. Patients having no known complication of disease. 4. Diagnosed case of stage-1E.H.T would be selected for study (as per JNC.)

Exclusion criteria

Exclusion criteria: 1. 1. Patients below age of 18 years and above 59 years. 2. Patients having secondary hypertension. 3. Patents having systemic / serious complications of Cardiovascular / Cerebrovascular / Renal System. 4. Pregnant patients. 5. Patients on Oral Contraceptive Pills. 6. History of liver disease in the recent past. 7. Hypertension- Retinopathy

Design outcomes

Primary

Measure	Time frame
Reduction in Systolic and Diastolic blood pressersTimepoint: 16 months	—

Secondary

Measure	Time frame
Reduction in Subjective parameters of Essential HypertensionTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Udai Raj Saroj

Department of Kayachikitsa NIA Jaipur

ursarojayu@gmail.com9983341119

Outcome results